Outcome and Biomarker Analysis from a Multicenter Phase 2 Study of Ipilimumab in Combination with Carboplatin and Etoposide as First-Line Therapy for Extensive-Stage SCLC-Reference-Cited by-同舟云学术

Outcome and Biomarker Analysis from a Multicenter Phase 2 Study of Ipilimumab in Combination with Carboplatin and Etoposide as First-Line Therapy for Extensive-Stage SCLC

Published:2016-09 Issue:9 Volume:11 Page:1511-1521
ISSN:1556-0864
Container-title:Journal of Thoracic Oncology
language:en
Short-container-title:Journal of Thoracic Oncology

Author:

Arriola Edurne,Wheater Matthew,Galea Ian,Cross Nadia,Maishman Tom,Hamid Debbie,Stanton Louise,Cave Judith,Geldart Tom,Mulatero Clive,Potter Vannessa,Danson Sarah,Woll Pennella J.,Griffiths Richard,Nolan Luke,Ottensmeier Christian

Funder

Bristol-Myers Squibb and Cancer Research UK

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine,Oncology

Reference43 articles.

1. Twenty-seven years of phase III trials for patients with extensive disease small-cell lung cancer: disappointing results;Oze;PloS One,2009

2. Use of thoracic radiotherapy for extensive stage small-cell lung cancer: a phase 3 randomised controlled trial;Slotman;Lancet,2015

3. A randomized comparison of standard chemotherapy versus alternating chemotherapy and maintenance versus no maintenance therapy for extensive-stage small-cell lung cancer: a phase III study of the Eastern Cooperative Oncology Group;Ettinger;J Clin Oncol,1990

4. Phase II study of vandetanib or placebo in small-cell lung cancer patients after complete or partial response to induction chemotherapy with or without radiation therapy: National Cancer Institute of Canada Clinical Trials Group Study BR.20;Arnold;J Clin Oncol,2007

5. Phase III double-blind, placebo-controlled study of thalidomide in extensive-disease small-cell lung cancer after response to chemotherapy: an intergroup study FNCLCC cleo04 IFCT 00-01;Pujol;J Clin Oncol,2007

Cited by 99 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advances in predictive biomarkers associated with immunotherapy in extensive-stage small cell lung cancer;Cell & Bioscience;2024-09-12

2. The Biological Role of Macrophage in Lung and Its Implications in Lung Cancer Immunotherapy;Advanced Biology;2024-04-29

3. Tissue and circulating biomarkers of benefit to immunotherapy in extensive-stage small cell lung cancer patients;Frontiers in Immunology;2024-01-29

4. Immunotherapy for Small Cell Lung Cancer;Journal of Biosciences and Medicines;2024

5. Deciphering the Role of Immune-Checkpoint Inhibitors in Lung Cancer Treatment;Molecular Biomarkers for Cancer Diagnosis and Therapy;2024